Hisham Shiblaq - Jun 6, 2025 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
EVP, Chief Comm. Officer
Signature
/s/ Jonathan Stone, Attorney-in-Fact for Hisham Shiblaq
Stock symbol
PRCT
Transactions as of
Jun 6, 2025
Transactions value $
-$1,179,037
Form type
4
Date filed
6/6/2025, 04:02 PM
Previous filing
Mar 19, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shiblaq Hisham EVP, Chief Comm. Officer C/O PROCEPT BIOROBOTICS CORPORATION, 150 BAYTECH DRIVE, SAN JOSE /s/ Jonathan Stone, Attorney-in-Fact for Hisham Shiblaq 2025-06-06 0001739363

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Options Exercise $104K +20K +31.68% $5.18 83.1K Jun 6, 2025 Direct
transaction PRCT Common Stock Sale -$783K -12.3K -14.79% $63.71 70.8K Jun 6, 2025 Direct F1
transaction PRCT Common Stock Sale -$382K -5.9K -8.33% $64.64 64.9K Jun 6, 2025 Direct F2
transaction PRCT Common Stock Sale -$118K -1.8K -2.77% $65.35 63.1K Jun 6, 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRCT Stock Option (Right to Buy) Options Exercise $0 -20K -63.34% $0.00 11.6K Jun 6, 2025 Common Stock 20K $5.18 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.24 to $64.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.24 to $65.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.29 to $65.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F4 The stock option is fully vested and exercisable.